Abid Hussain

机构：Chinese Academy of Sciences, Chengdu Institute of Biology · ORCID：0000-0002-0640-4730

发表论文 60 篇 · 总被引 1839 次 · h-index 23

代表论文

• The landscape of nanoparticle-based siRNA delivery and therapeutic development (2024 · Molecular Therapy · 被引 207)
• mRNA vaccines for COVID-19 and diverse diseases (2022 · Journal of Controlled Release · 被引 111)
• Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia (2022 · Science Advances · 被引 94)
• Exosome regulation of immune response mechanism: Pros and cons in immunotherapy (2023 · Bioactive Materials · 被引 74)
• Atavistic strategy for the treatment of hyperuricemia via ionizable liposomal mRNA (2024 · Nature Communications · 被引 42)
• Bioimaging guided pharmaceutical evaluations of nanomedicines for clinical translations (2022 · Journal of Nanobiotechnology · 被引 36)